|
JP2003088388A
|
|
NEW FULL-LENGTH cDNA
|
|
JP2005229809A
|
|
Established fat precursor cell, method for preparing the same and method for using the same
|
|
JP2002078493A
|
|
New gene related to cell proliferation and gene expression control, and protein encoded by the gene
|
|
JP2002132780A
|
|
Gene array expression system and recording medium
|
|
JP2002108877A
|
|
Method for comparing gene appearance frequency distribution and recording medium
|
|
JP2002191363A
|
|
PRIMER FOR WHOLE LENGTH cDNA SYNTHESIS AND ITS USE
|
|
JP2002017376A
|
|
Secretory protein or membrane protein
|
|
JP2002017375A
|
|
Primer for synthesizing whole length cyclic dna and its use
|
|
JP2002171977A
|
|
New human sh2 protein
|
|
JP2001149074A
|
|
New tbp bond protein
|
|
JP2000050882A
|
|
Peptide having transitional activity to nucleus
|
|
JP2000300263A
|
|
Proteins '410' and 'new' involved in blood vessel neogenesis, and genes coding for the proteins
|
|
JP2000308488A
|
|
Protein which is related to blood vessel neogenesis and gene coding for the protein
|
|
JP2000217576A
|
|
Induction of differentiation into adipocyte, compound which controls differentiation into adipocyte, and its screening
|
|
JP2000152790A
|
|
Protein relevant to proliferation of neurocyte and gene coding for the protein
|
|
JP2000050881A
|
|
New nucleolus protein
|
|
JP2000072796A
|
|
Identification of proteins having specific function
|
|
JP2000072693A
|
|
Medicine to be injected into spleen
|
